Apyx Medical Corp

APYXNasdaqCIK 719135HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 290 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Apyx Medical Corp, Reports and events
Filed	Form	What it is	Accession number
2018-03-1216:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-18-000013
2017-12-1807:26 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0000719135-17-000070
2017-11-1317:28 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events	0000719135-17-000067
2017-11-0307:42 ET	10-Q	Quarterly reportPeriod 2017-09-30	0000719135-17-000064
2017-11-0217:17 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-17-000062
2017-09-1508:14 ET	8-K	5.07 Shareholder vote results	0000719135-17-000039
2017-08-0716:57 ET	DEF 14A	Proxy statementPeriod 2017-09-14	0000719135-17-000032
2017-08-0307:17 ET	10-Q	Quarterly reportPeriod 2017-06-30	0000719135-17-000029
2017-08-0217:16 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-17-000027
2017-07-2807:46 ET	DEF 14A	Proxy statementPeriod 2017-09-14	0000719135-17-000020
2017-05-1517:05 ET	10-Q	Quarterly reportPeriod 2017-03-31	0000719135-17-000016
2017-05-1517:02 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-17-000015
2017-03-1007:32 ET	10-K	Annual reportPeriod 2016-12-31	0000719135-17-000009
2017-03-1018:06 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000719135-17-000007
2016-12-2216:56 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events	0001009448-16-000086
2016-11-2317:03 ET	SC 13D/A	Ownership report, active investor, amended	0000930413-16-008811
2016-11-2321:54 ET	SC 13D/A	Ownership report, active investor, amended	0000930413-16-008801
2016-11-1816:20 ET	8-K	8.01 Other events	0001009448-16-000063
2016-11-1421:29 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-16-766247
2016-10-3112:07 ET	10-K/A	Annual report, amendedPeriod 2013-12-31	0001009448-16-000059
2016-10-3112:06 ET	10-K/A	Annual report, amendedPeriod 2014-12-31	0001009448-16-000057
2016-10-3112:05 ET	10-K/A	Annual report, amendedPeriod 2015-12-31	0001009448-16-000055
2016-10-2714:12 ET	8-K	9.01 Financial statements and exhibits	0001009448-16-000052
2016-10-2708:01 ET	10-Q	Quarterly reportPeriod 2016-09-30	0001477932-16-013130
2016-08-0212:40 ET	8-K	5.07 Shareholder vote results	0001009448-16-000046
2016-08-0208:22 ET	10-Q	Quarterly reportPeriod 2016-06-30	0001477932-16-011605
2016-08-0116:35 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001009448-16-000044
2016-07-0516:34 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001009448-16-000042
2016-06-1013:00 ET	DEF 14A	Proxy statementPeriod 2016-06-10	0001477932-16-010780
2016-05-1116:06 ET	10-Q	Quarterly reportPeriod 2016-03-31	0001477932-16-010184
2016-05-1115:59 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001009448-16-000039
2016-04-2115:55 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001009448-16-000035
2016-03-1808:32 ET	10-K	Annual reportPeriod 2015-12-31	0001477932-16-009087
2016-03-1808:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001477932-16-009086
2016-02-2617:19 ET	SC 13D	Ownership report, active investor	0000930413-16-005714
2015-11-0517:00 ET	10-Q	Quarterly reportPeriod 2015-09-30	0001477932-15-006786
2015-11-0508:25 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001009448-15-000028
2015-10-2316:01 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001477932-15-006603
2015-10-1916:09 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001009448-15-000026
2015-08-1209:41 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001009448-15-000016
2015-08-0712:47 ET	10-Q	Quarterly reportPeriod 2015-06-30	0001477932-15-004925
2015-08-0616:43 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001009448-15-000014
2015-07-1715:30 ET	8-K	5.07 Shareholder vote results	0001009448-15-000012
2015-06-1516:21 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001477932-15-003866
2015-05-2916:10 ET	DEF 14A	Proxy statementPeriod 2015-05-29	0001477932-15-003618
2015-05-0813:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001477932-15-002958
2015-05-0810:45 ET	8-K	5.02 Departure or appointment of officers or directors	0001477932-15-002948
2015-05-0810:44 ET	10-Q	Quarterly reportPeriod 2015-03-31	0001477932-15-002946
2015-03-3112:36 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001477932-15-002056
2015-03-1711:41 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits	0001477932-15-001748

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 13:09 ET. Listed shows no prices and gives no investment advice.